Stoke Therapeutics Stock Performance
as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
$21.37$22.89
5.11%
Downside
1.64%
Upside
52 Week's Low
52 Week's High
$5.35$38.6976.24%
Downside
71.82%
Upside
Stoke Therapeutics share price movements today
- Previous Close
- $22.82
- Open
- $22.68
- Volume
- 1.1M
- Day's Low - High
- $21.37 - $22.89
- 52 Week Low - High
- $5.35 - $38.69
Stoke Therapeutics Historical Returns
- 1 Month Return
- -14.88 %
- 3 Month Return
- + 73.27 %
- 1 Year Return
- + 72.23 %
- 3 Year Return
- + 95.21 %
- 5 Year Return
- -42.76 %
Stoke Therapeutics Stock Fundamentals & Key Indicators
Check Stoke Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
0.3079
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
30.17
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
42.3M
Revenue (TTM)
199.9M
Profit Margin
26.26%
Return On Equity TTM
18.17%
Stoke Therapeutics Stock Valuation
Track how Stoke Therapeutics P/E has moved over time to understand its valuation trends.
Stoke Therapeutics in the last 5 years
Lowest (-33.89x)
March 31, 2021
Industry (-0.81x)
November 6, 2025
Today (30.17x)
November 6, 2025
Highest (12.98x)
September 30, 2025
Today’s Price to Earnings Ratio: 30.17x
Stoke Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Stoke Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | -42.76% | 30.17 | 26.26% | |
| BUY | $39.9B | 473.78% | -16.34 | -264.83% | |
| BUY | $55.9B | 232.41% | 1411.57 | 1.36% | |
| BUY | $108.1B | 89.3% | 29.63 | 31.86% | |
| BUY | $67.5B | 11.45% | 15.38 | 32.13% |
Stock Returns calculator for Stoke Therapeutics Stock including INR - Dollar returns
The Stoke Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Stoke Therapeutics investment value today
Current value as on today
₹1,74,998
Returns
₹74,998
(+75%)
Returns from Stoke Therapeutics Stock
₹69,962 (+69.96%)
Dollar Returns*
₹5,036 (+5.04%)
Analyst Recommendation on Stoke Therapeutics Stock
Based on 15 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Stoke Therapeutics. Average target price of $29.78
Stoke Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Stoke Therapeutics.
What analysts predicted
24.38%UPSIDE
Target Price
$29.78
Current Price
$22.52
Analyzed by
15 Analysts
Target
$29.78
Stoke Therapeutics target price $29.78, a slight upside of 24.38% compared to current price of $22.52. According to 15 analysts rating.
Stoke Therapeutics Stock’s Investor Sentiment and Interest
Search interest for Stoke Therapeutics Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:71% versus previous 30 day period
Stoke Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Stoke Therapeutics Annual Profit & Loss
All numbers in Millions USD
Stoke Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Stoke Therapeutics Annual Cash Flow
All numbers in Millions USD
Stoke Therapeutics News & Key Events
Today's Timeline - 06 October
Mon, 05:37 PM
-Stoke Therapeutics appoints Ian F. Smith as permanent CEO, effective October 6, 2025, emphasizing leadership stability and growth.
Insights on Stoke Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 156.5% return, outperforming this stock by 84.3%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 926.8% return, outperforming this stock by 831.6%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 112.87M → -23.48M (in $), with an average decrease of 120.8% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 158.56M → 13.81M (in $), with an average decrease of 91.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, STOK stock has moved down by -28.0%
About Stoke Therapeutics
| Organisation | Stoke Therapeutics |
| Headquarters | 45 Wiggins Avenue, Bedford, MA, United States, 01730 |
| Industry | Health Technology |
| CEO | Mr. Ian F. Smith A.C.A., C.P.A. |
| E-voting on shares | Click here to vote |
Key Management of Stoke Therapeutics
Name | Title |
|---|---|
Doug Snow | Director of Communications & Investor Relations |
Mr. Ian F. Smith A.C.A., C.P.A. | CEO & Director |
Dr. Adrian R. Krainer Ph.D. | Co-Founder & Independent Director |
Mr. Thomas Edward Leggett | Chief Financial Officer |
Ms. Isabel Aznarez Ph.D. | Co-Founder, Head of Research & Senior VP |
Ms. Sara Den Besten | Chief People Officer |
Dr. Edward M. Kaye M.D., Ph.D. | Advisor & Director |
Dr. Barry S. Ticho FACC, M.D., Ph.D. | Chief Medical Officer |
Mr. Jonathan Allan J.D. | Corporate Secretary & General Counsel |
Ms. Dawn Kalmar | Chief Communications Officer |
FAQs
What is Stoke Therapeutics share price today?
Stoke Therapeutics share price today is $22.52 as on at the close of the market. Stoke Therapeutics share today touched a day high of $22.89 and a low of $21.37.
What is the 52 week high and 52 week low for Stoke Therapeutics share?
Stoke Therapeutics share touched a 52 week high of $38.69 on and a 52 week low of $5.35 on . Stoke Therapeutics stock price today i.e. is closed at $22.52,which is 41.80% down from its 52 week high and 320.93% up from its 52 week low.
What is Stoke Therapeutics's market capitalisation today?
Stoke Therapeutics market capitalisation is $0.00T as on .
How to invest in Stoke Therapeutics Stock (STOK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Stoke Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Stoke Therapeutics Shares that will get you 0.0666 shares as per Stoke Therapeutics share price of $22.52 per share as on November 7, 2025 at 2:29 am IST.
What is the minimum amount required to buy Stoke Therapeutics Stock (STOK) from India?
Indian investors can start investing in Stoke Therapeutics (STOK) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Stoke Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Stoke Therapeutics share’s latest price of $22.52 as on November 7, 2025 at 2:29 am IST, you will get 0.4440 shares of Stoke Therapeutics. Learn more about
fractional shares .
What are the returns that Stoke Therapeutics has given to Indian investors in the last 5 years?
Stoke Therapeutics stock has given -42.76% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?